Sanofi announced positive results from the pivotal Phase 3 LIBERTY-AFRS-AIMS trial showing Dupixent significantly improved outcomes for adults and children aged 6 years and older with allergic fungal ...

Sanofi has cited security concerns about planned highrises near its plant, while the developer says the provincial order ...

Sanofi Consumer Healthcare India Limited said on Thursday that its third-quarter profit jumped 40% to ₹62.9 crore and revenue ...

Sanofi Consumer Healthcare India (SCHIL) soared 8.47% to Rs 5,052 after the company reported a strong performance for the quarter ended 30 September 2025.

In November 2025, SOE Medical Procurement of Ukraine renegotiated the managed entry agreements (MEAs) with the international ...

A new Merck pill called enlicitide slashes levels of harmful LDL cholesterol by up to 60%, similar to injectable PCSK9 drugs ...

The project will expand Boryung’s oral penicillin antibiotic production line at its campus in Ansan, South Korea, from 2,777 ...

Third Arc Bio is paying $5 million upfront to use Adagene’s tech in hopes of creating two new masked T-cell engagers. | Third ...

Korro Bio shares drop after KRRO-110 trial in AATD misses protein goals; company cuts 34% of staff and shifts focus to ...

After multiple clinical setbacks and layoff rounds, Mersana accepted an offer in which the bulk of the payouts will only ...

Achieved additional $75 million in partnering proceeds from Sanofi and GileadGranted license to additional preclinical program to Gilead that ...

THURSDAY, Nov. 13, 2025 (HealthDay News) — A new pill from Merck could change how millions of people treat high cholesterol ...